SMURF2 targets HIF1α for ubiquitination, leading to its proteasomal degradation, which disrupts key adaptive processes such as the Warburg effect—where cancer cells shift towards aerobic glycolysis for rapid ATP production, contributing to an acidic microenvironment that furthers tumor progression and therapy resistance (4). The gene discussed is SMURF2; the disease is cancer.